Dr Martin Everett

Dr Martin Everett
Dr Martin Everett
Chief Scientific Officer

Presentations at Drug Discovery 2021 After the Storm: Re-connect, Re-invent, Re-imagine

Profile of Dr Martin Everett

Martin has over 30 years’ experience in academia, pharmaceutical R&D (GSK) and biotechnology (MerLion, ANTABIO) as a drug discovery scientist, with a particular interest in antibiotic resistance/persistence mechanisms. At GSK he managed a high-throughput screening group and led several lead discovery projects. At MerLion he was Head of Research leading a multi-disciplinary team discovering novel natural product derived compounds. At ANTABIO, Martin is the CSO and heads up all R&D activities, which includes teams in France, UK and USA. He is PI for ANTABIO’s Pseudomonas Elastase inhibitor programme, supported by CARB-X.


Please login to send a Private Message

Hosted By

The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Event Logo Find us on Facebook Follow us on Twitter

Get the App

Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
Eventflo Home
copyright ELRIG, eventflo.co.uk, Labhoo Ltd 2003-2021